EPIVX
Price
$13.91
Change
-$0.00 (-0.00%)
Updated
Nov 19 closing price
Net Assets
175.03M
HFQRX
Price
$6.96
Change
-$0.05 (-0.71%)
Updated
Nov 19 closing price
Net Assets
6.7B
Interact to see
Advertisement

EPIVX vs HFQRX

Header iconEPIVX vs HFQRX Comparison
Open Charts EPIVX vs HFQRXBanner chart's image
EuroPac International Value A
Price$13.91
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets175.03M
Janus Henderson Global Equity Income N
Price$6.96
Change-$0.05 (-0.71%)
VolumeN/A
Net Assets6.7B
EPIVX vs HFQRX Comparison Chart in %
View a ticker or compare two or three
VS
EPIVX vs. HFQRX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPIVX is a Hold and HFQRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 6.7B vs. EPIVX (175M). HFQRX pays higher dividends than EPIVX: HFQRX (7.24) vs EPIVX (1.26). EPIVX was incepted earlier than HFQRX: EPIVX (16 years) vs HFQRX (10 years). EPIVX (1.73) is less costly to investors than HFQRX (0.70). HFQRX is a more actively managed with annual turnover of: 155.00 vs. EPIVX (20.00). EPIVX has a lower initial minimum investment than HFQRX: EPIVX (2500) vs HFQRX (1000000). EPIVX annual gain was more profitable for investors over the last year : 31.22 vs. HFQRX (20.72). EPIVX return over 5 years is better than : 76.29 vs. HFQRX (59.64).
EPIVXHFQRXEPIVX / HFQRX
Total Expense Ratio1.730.70247%
Annual Report Gross Expense Ratio1.730.70247%
Fund Existence16 years10 years-
Gain YTD36.49022.066165%
Front Load5%N/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets175M6.7B3%
Annual Yield % from dividends1.267.2417%
Returns for 1 year31.2220.72151%
Returns for 3 years63.4145.56139%
Returns for 5 years76.2959.64128%
Returns for 10 years155.19N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIMAX7.39N/A
N/A
Cromwell Tran Sustainable Focus Investor
AUICX35.52N/A
N/A
AB Equity Income C
ARIGX17.43N/A
N/A
Aristotle Growth Equity I
AUENX21.43-0.08
-0.37%
AQR Large Cap Defensive Style N
OAKLX83.37-0.32
-0.38%
Oakmark Select Investor